Erste Asset Management’s MacroGenics MGNX Stock Holding History
Bought
Maintained
Sold
Other funds holding MGNX
BG
RCM
AC
WA
RI
PA
Erste Asset Management's MGNX Position: Q1 2022 in Review
Erste Asset Management sold out of MacroGenics (MGNX) in Q1 2022, closing a stake of 18,000 shares — an estimated $286K sold.
Erste Asset Management first reported a position in MGNX in Q4 2018 and held it in 8 quarters. The position peaked at $560K in Q1 2021. 144 funds tracked by Wall St. Rank hold MGNX as of Q1 2022.
- Erste Asset Management reported no remaining MacroGenics position as of Q1 2022 after selling out during the quarter.
- Erste Asset Management sold 18,000 MacroGenics shares in Q1 2022, an estimated $286K.
- Erste Asset Management first reported a position in MacroGenics in Q4 2018 and held it in 8 quarters.
- Erste Asset Management's MacroGenics position peaked at $560K in Q1 2021.
- 144 funds tracked by Wall St. Rank held MacroGenics as of Q1 2022.
Based on Erste Asset Management's 13F filing for Q1 2022, filed 25 Nov 2024.